Suppr超能文献

鼻咽癌外照射后甲状腺放射性改变的纵向研究。

A longitudinal study on the radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma.

机构信息

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

出版信息

Thyroid. 2011 Jan;21(1):19-23. doi: 10.1089/thy.2010.0229. Epub 2010 Nov 8.

Abstract

BACKGROUND

Radiation-induced thyroid disorders have been reported in radiotherapy of head and neck cancers. This study evaluated the radiation-induced damages to thyroid gland in patients with nasopharyngeal carcinoma (NPC).

METHODS

Forty-five patients with NPC treated by radiotherapy underwent baseline thyroid hormones (free triiodothyronine, free thyroxine [fT4], and thyrotropin [TSH]) examination and CT scan before radiotherapy. The volume of the thyroid gland was calculated by delineating the structure in the corresponding CT slices using the radiotherapy treatment planning system. The thyroid doses were estimated using the treatment planning system. Subsequent CT scans were conducted at 6, 12, and 18 months after radiotherapy, whereas the hormone levels were assessed at 3, 6, 12, and 18 months after radiotherapy. Trend lines of the volume and hormone level changes against time were plotted. The relationship between the dose and the change of thyroid volume and hormone levels were evaluated using the Pearson correlation test.

RESULTS

An average of 20% thyroid volume reduction in the first 6 months and a further 8% shrinkage at 12 months after radiotherapy were observed. The volume reduction was dependent on the mean thyroid doses at 6, 12, and 18 months after radiotherapy (r = -0.399, -0.472, and -0.417, respectively). Serum free triiodothyronine and fT4 levels showed mild changes of <2.5% at 6 months, started to drop by 8.8% and 11.3%, respectively, at 12 months, and became stable at 18 months. The mean serum TSH level increased mildly at 6 months after radiotherapy and more steeply after 18 months. At 18 months after radiotherapy, 12 patients had primary hypothyroidism with an elevated serum TSH, in which 4 of them also presented with low serum fT4. There was a significant difference (p = 0.014) in the mean thyroid doses between patients with hypothyroidism and normal thyroid function.

CONCLUSIONS

Radiotherapy for patients with NPC caused radiation-induced changes of the thyroid gland. The shrinkage of the gland was greatest in the first 6 months after radiotherapy, whereas the serum fT4 and TSH levels changed at 12 months. Radiation-induced changes were dependent on the mean dose to the gland. Therefore, measures to reduce the thyroid dose in radiotherapy should be considered.

摘要

背景

头颈部癌症放疗后可引发甲状腺功能障碍。本研究评估了鼻咽癌(NPC)患者放疗后甲状腺的放射性损伤。

方法

45 例 NPC 患者在放疗前行基线甲状腺激素(游离三碘甲状腺原氨酸、游离甲状腺素[fT4]和促甲状腺激素[TSH])检查和 CT 扫描。通过勾画放疗计划系统中相应 CT 层面的结构,计算甲状腺体积。采用放疗计划系统估算甲状腺剂量。放疗后 6、12 和 18 个月进行后续 CT 扫描,放疗后 3、6、12 和 18 个月评估激素水平。绘制体积和激素水平随时间变化的趋势线。采用 Pearson 相关检验评估剂量与甲状腺体积和激素水平变化的关系。

结果

放疗后前 6 个月甲状腺体积平均缩小 20%,12 个月后进一步缩小 8%。体积缩小与放疗后 6、12 和 18 个月的平均甲状腺剂量相关(r 值分别为-0.399、-0.472 和-0.417)。放疗后 6 个月游离三碘甲状腺原氨酸和 fT4 水平轻度变化,<2.5%,12 个月时分别下降 8.8%和 11.3%,18 个月时稳定。放疗后 6 个月时 TSH 平均水平轻度升高,18 个月后升高更明显。放疗后 18 个月时,12 例患者出现原发性甲状腺功能减退,血清 TSH 升高,其中 4 例也伴有低血清 fT4。甲状腺功能减退症和甲状腺功能正常患者的平均甲状腺剂量有显著差异(p=0.014)。

结论

NPC 患者放疗后可引起甲状腺放射性改变。放疗后 6 个月内腺体缩小最明显,12 个月时 fT4 和 TSH 水平发生变化。放射性改变与腺体的平均剂量有关。因此,放疗中应考虑降低甲状腺剂量的措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验